We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+21.26%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.77B
AUM Growth
+$720M
(+24%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
7.43%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
294
New
116
Increased
45
Reduced
52
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$115M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$93.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$57.1M |
| 4 |
Eli Lilly
LLY
|
+$51.1M |
| 5 |
Qorvo
QRVO
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$72.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$66.5M |
| 3 |
Amazon
AMZN
|
+$65.6M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$58.8M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.9% |
| 2 | Technology | 32.83% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 3.92% |
| 5 | Consumer Discretionary | 3.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$203B
| $115M | 3.05% |
+500,520
| New | +$115M |
|
|
2
Alphabet (Google) Class A
GOOGL
$3.91T
| $97.8M | 2.59% |
+1,115,980
| New | +$93.9M |
|
3
Amphenol
APH
$188B
| $95.2M | 2.52% |
2,912,400
+1,366,968
| +88% | +$42M |
|
4
Fidelity National Information Services
FIS
$21.5B
| $90M | 2.39% |
636,528
-276,227
| -30% | -$39.4M |
|
5
Johnson & Johnson
JNJ
$635B
| $88.5M | 2.35% |
562,224
-269,985
| -32% | -$39.8M |
|
6
Global Payments
GPN
$22.1B
| $86.5M | 2.29% |
401,588
-218,037
| -35% | -$40.7M |
|
|
ATVI
7
DELISTED
Activision Blizzard
ATVI
| $71.3M | 1.89% |
768,029
-322,374
| -30% | -$26.2M |
|
|
8
Eli Lilly
LLY
$1.07T
| $69.2M | 1.83% |
409,850
+341,943
| +504% | +$51.1M |
|
9
Medtronic
MDT
$107B
| $68.7M | 1.82% |
586,448
+162,692
| +38% | +$17.9M |
|
|
10
NXP Semiconductors
NXPI
$68B
| $61.6M | 1.63% |
+387,399
| New | +$57.1M |
|
11
Vishay Intertechnology
VSH
$5.86B
| $59.1M | 1.57% |
2,855,172
-367,024
| -11% | -$6.77M |
|
12
Lumentum
LITE
$59.4B
| $58.9M | 1.56% |
620,808
+128,907
| +26% | +$11.1M |
|
13
Micron Technology
MU
$1.04T
| $58.2M | 1.54% |
774,125
+545,378
| +238% | +$32.9M |
|
14
Take-Two Interactive
TTWO
$43B
| $57.2M | 1.52% |
275,382
-18,188
| -6% | -$3.18M |
|
|
15
Qorvo
QRVO
$7.63B
| $53.9M | 1.43% |
+323,901
| New | +$47.7M |
|
16
Mastercard
MA
$477B
| $53.7M | 1.42% |
150,368
-37,189
| -20% | -$12.4M |
|
17
Applied Materials
AMAT
$426B
| $53.4M | 1.42% |
618,417
-172,044
| -22% | -$12.7M |
|
18
Texas Instruments
TXN
$255B
| $52M | 1.38% |
317,108
+78,141
| +33% | +$12.1M |
|
|
IGMS
19
DELISTED
IGM Biosciences
IGMS
| $47.7M | 1.27% |
540,416
+450,038
| +498% | +$31.6M |
|
20
Expedia Group
EXPE
$31.2B
| $45.4M | 1.2% |
+342,916
| New | +$38.6M |
|
21
ASML
ASML
$675B
| $45.3M | 1.2% |
+92,884
| New | +$39.1M |
|
22
Arrow Electronics
ARW
$10.9B
| $43.7M | 1.16% |
449,556
-123,069
| -21% | -$10.9M |
|
23
Alkermes
ALKS
$8.82B
| $42.7M | 1.13% |
2,141,369
-355,450
| -14% | -$6.5M |
|
24
MarketWise
MKTW
$53.1M
| $41.1M | 1.09% |
200,439
| – | – |
|
|
KLRS
25
Kalaris Therapeutics
KLRS
$88.7M
| $40M | 1.06% |
45,212
-6,571
| -13% | -$5.06M |
|
Similar funds
KAS
PAM
TCIIS
Woodline Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Woodline Partners held 294 positions worth $3.77B, up 24% from $3.05B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Woodline Partners deployed $280M of net new capital in Q4 2020, opening 116 new positions and adding to 45 existing holdings. Its largest new stake was Amgen: 500,520 shares worth $115M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $58.8M trimmed.
- Woodline Partners's largest Q4 2020 buy was Amgen: 500,520 shares worth $115M.
- Woodline Partners added most to Eli Lilly in Q4 2020, an estimated $51.1M increase.
- Woodline Partners's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $58.8M.
- Woodline Partners fully exited Microchip Technology in Q4 2020, selling an estimated $72.6M.
- Woodline Partners's ten largest holdings make up 22% of its $3.77B portfolio in Q4 2020.
- Woodline Partners opened 116 new positions and closed 77 in Q4 2020.
- Woodline Partners's portfolio value rose 24% quarter-over-quarter to $3.77B.
Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.